Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00975585 · ClinicalTrials.gov registry record · NA

Clinical Performance Comparison of Two Contact Lenses

A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
379
Enrollment target
20
Study locations

NCT00975585 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 379 participants, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (44% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00975585, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
379 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to compare the clinical performance of two contact lenses.

Conditions Studied

Interventions

  • DEVICE senofilcon A
  • DEVICE lotrafilcon B

Study Locations (20)

Florida

  • - Jacksonville
  • - Jacksonville
  • - Miami
  • - Winter Park

Ohio

  • - Chagrin Falls
  • - North Olmsted
  • - Warren

Massachusetts

  • - Boston
  • - Cambridge

South Dakota

  • - Chamberlain
  • - Hot Springs

Arkansas

  • - North Little Rock

California

  • - Campbell

Colorado

  • - Colorado Springs

Georgia

  • - Roswell

Trial Details

FieldValue
Enrollment Target 379 participants
Start Date 2009-08-01
Est. Completion 2009-10-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT00975585

The ClinicalTrials.gov registry entry for NCT00975585 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (44% higher). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A is the first listed.

NCT00975585 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Ohio, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00975585 about?

NCT00975585 is a clinical study titled "Clinical Performance Comparison of Two Contact Lenses". The purpose of this study is to compare the clinical performance of two contact lenses.

What is the current status of trial NCT00975585?

This trial is currently completed. It is a NA study. The enrollment target is 379 participants. The study started on 2009-08-01. Estimated completion is 2009-10-01.

What conditions does trial NCT00975585 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT00975585?

The interventions under investigation include: senofilcon A (DEVICE), lotrafilcon B (DEVICE).

Who is sponsoring clinical trial NCT00975585?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00975585 being conducted?

This trial has 20 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.